There were 945 press releases posted in the last 24 hours and 432,456 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Teneobio Doses First Patient in Phase 1 Study of TNB-383B for the Treatment of Patients with Multiple Myeloma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image